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October 2018 Newsletter  
 
 
 
 
 
 
CCTS SPARK Program 
Application Deadline: Rolling Basis 
THE UMCCTS SPARK (Small Pilot and Research Knowledge) Program’s priorities are to support studies that 
impact clinical care and research methodologies, support students and trainees, and provide access to funds 
to generate pilot and preliminary data for external grant submissions. 
For more information: https://www.umassmed.edu/ccts/funding/spark-program/  
CCTS Small Conference Grants 
Application Deadline: Rolling Basis 
THE UMCCTS is pleased to offer Small Conference Grants (SCG). This funding facilitates the development of 
faculty-to-faculty networks within the University system. 
For more information: https://www.umassmed.edu/ccts/funding/small-conference-grants/  
DRIVe's EZ-BAA application process is now open for business!  
 
Calling all medical product developers, research teams, and companies! Those offering disruptive 
innovative approaches that will transform health security threats are now invited to submit abstracts 
using DRIVe's simplified EZ-BAA process. Applications must offer transformative innovation, 
products, and technologies to protect Americans from health security threats.  
In-scope priority areas include: 
• Products and solutions to reduce illness and death from sepsis as part of DRIVe's Solving Sepsis 
Initiative 
• Technologies and processes to identify infections and exposures to biological and other health 
threats, as outlined in the Early Notification to Act, Control, and Treat (ENACT) initiative 
• Tools and techniques to mitigate the damages and loss of life associated with catastrophic events 
Download the application and learn about next steps here. 
Learn more about the DRIVe EZ-BAA review criteria.  
Have questions or looking for more information? Contact DRIVeContracting@hhs.gov  
 
Collaborative Funding Opportunities 
CLIC is pleased to announce two funding opportunities for collaborative efforts to help advance translational 
and team science throughout the consortium. Teams are invited to apply for support to write a Synergy Paper 
or host an Un-Meeting. More information and all application requirements can be found on CLIC’s website: 
Synergy Paper Request for Applications  
NCATS Funding Available to Repurpose Existing Drugs 
NCATS has announced funding opportunities to use partially developed therapeutic candidates to identify new 
treatments for a broad range of diseases. 
Full details here: https://ncats.nih.gov/news/releases/2018/ntu-foa-2018  
Announcement of the NCATS Rare Diseases Are Not Rare! Challenge 
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The National Center for Advancing Translational Sciences (NCATS) is seeking innovative ways to 
communicate with others to educate people about rare diseases through social media or art. The goal of this 
challenge is threefold: First and foremost, it is to raise awareness for all rare diseases in a collective manner. 
Second, it is intended to bring attention to the many people with rare diseases; and finally, it is to highlight the 
need for research and the development of new treatments.  
Solutions must be submitted to www.challenge.gov by NOON Eastern time on October 28, 2018.  
 
 
 
 
 
 
K Club 
The CCTS Research Career & Writing Group (K-Club) meets every first and third Wednesday to provide 
information and feedback on Research Career Award applications (NIH K Awards, VA Research Career 
Awards, CTSA K grants, etc.). Participants receive feedback on their biosketch, training plans, research plan, 
specific aims, and a wealth of other information.  
Where: 1st and 3rd Wednesday of the month from 4:00pm - 5:00pm in ASC5-2072 
More information: https://www.umassmed.edu/ccts/education/k-club  
Projects in Progress Seminar Series (PiPSS) 
PiPSS is designed to give CCTS trainees and junior faculty an opportunity to present their work in a structured 
format and in a forum of peers and faculty with the goal of ensuring continuous, professional feedback and 
cross-fertilization that is required for excellence in research. The first session of the 2018-19 academic year will 
be on Thursday, October 18th at 3:30PM in Room ASC8-2072 (Albert Sherman Building). 
The speakers will be: 
• Teresita Padilla-Benavides, PhD (FDSP) "Insights in mitochondrial metalloproteins during myogenesis" 
• Maggi Ahmed, MD (Millennium Program) "Melanocyte Keratinocyte Transplantation Procedure in 
Vitiligo: T Lymphocytes Impact the Outcomes" 
• James Strassner, BS (MD/PhD program) “IFNγ production by autoreactive T cells destroys 
melanocytes by downregulating retention integrins and survival signals during vitiligo” 
New Clinicaltrials.gov Education sessions have been added! 
Are you a PI or study team member for a human research study? Clinicaltrials.gov registration isn’t limited to 
drug or device trials: it can include any human research study which prospectively assigns participants to one 
or more intervention to evaluate the effects on health outcomes. It can include surgical and behavioral 
interventions as well as drug and device studies. Failure to properly register a trial can lead to denial of study 
publication, restriction in funding and civil monetary penalties. 
Join Meg Johnson (meg.johnson@umassmed.edu), HRPP Compliance Administrator and UMMS 
Clinicaltrials.gov point of contact to learn more about registration, maintenance and result reporting 
requirements for clinicaltrials.gov.  
Topic Date Time Prerequisite Registration Link 
Clinicaltrials.gov 
Basics: 
Registration 
10/25/18 1:00 
PM – 
2:00 
PM 
N 
https://i.umassmed.edu/inside/display/EventDisplay.aspx?sID=18475  
11/5/18 10:00 
AM 
–  
11:00 
AM 
N 
https://i.umassmed.edu/inside/display/EventDisplay.aspx?sID=18481  
11/28/18 11:00 
AM 
– 
N 
https://i.umassmed.edu/inside/display/EventDisplay.aspx?sID=18482  
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Research Study Design and Analysis Series 
Are you new to clinical and translational research? 
Or maybe you want to polish your skill set? 
Check out this upcoming educational series on study design and analysis! 
Session II: Design, Conduct, and Analysis of Randomized Controlled Trials 
In this second session, attendees will learn about the design, conduct, and analysis of randomized controlled 
clinical trials (RCTs). This two hour session will cover various topics that pertain to RCTs including the 
development of study hypotheses, trial design (including sample size/power estimation), patient recruitment 
and enrollment, reasons for randomization and common randomization approaches, data collection activities, 
data analysis (including interim and final analyses), and presentation. 
Date: October 16, 2018 
Time: 3:00 – 5:00 PM 
Location: Albert Sherman Building, 6th Floor, AS6-2072 
  
12:00 
PM 
     
Clinicaltrials.gov 
Intermediate: 
Registration 
10/23/18 1:00 
PM - 
2:00 
PM 
Y 
https://i.umassmed.edu/inside/display/EventDisplay.aspx?sID=18478  
10/26/18 10:00 
AM - 
11:00 
AM 
Y 
https://i.umassmed.edu/inside/display/EventDisplay.aspx?sID=18477  
11/6/18 2:00 
PM – 
3:00 
PM 
Y 
https://i.umassmed.edu/inside/display/EventDisplay.arpx?sID=18483  
 
11/29/18 11:00 
AM 
– 
12:00 
PM 
Y 
https://i.umassmed.edu/inside/display/EventDisplay.aspx?sID=18484  
     
Clinicaltrials.gov 
Basics: Record 
Maintenance 
and Results 
Reporting 
11/7/18 10:00 
AM - 
11:00 
AM 
Y 
https://i.umassmed.edu/inside/display/EventDisplay.aspx?sID=18485  
11/30/18 11:00 
AM 
– 
12:00 
PM 
Y 
https://i.umassmed.edu/inside/display/EventDisplay.aspx?sID=18486  
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Special Webinar-Presented by the Trials Innovation Network 
Title: Biobanking, Genomic Research – Medicine’s Brave New World: Understanding and Acceptance of 
Individuals Underrepresented in Clinical Trials 
Presented by: Terry Davis, PhD 
When: Wednesday, October 17, 2018, 12:00 – 1:00 PM 
To Register: https://register.gotowebinar.com/register/7566629408452081154  
QHS Special Seminar 
Title: Building the bridge between implementation research and implementation practice: from SIC to SIC-
Coaching 
Presented by: Lisa Saldana, PhD; Senior Scientist, Oregon Social Learning Center 
When: Tuesday, October 23, 2018, 12:00 – 1:00 PM 
Where: Albert Sherman Building, AS6-2072 
M2D2'S BARRACUDA BOWL 
October 23rd, 2018 | 5:00 pm - 9:00 pm 
Mintz Levin, 1 Financial Center, Boston MA 
 
Like "Shark Tank"—but instead of business pitches, M2D2 affiliate entrepreneurs will face off to present 
their medtech plans to a panel of judges. Will they thrive under the pressure or drown among the 
barracudas? 
Enjoy the show, network, and have some fun with us this October in Boston! 
 
QHS Grand Rounds Series 
Title: Hidden Bias in Health Care: A Decade of Research on Implicit Bias in Healthcare 
Presented by: Janice Sabin, Ph.D., MSW; Research Associate Professor; University of Washington 
When: Monday, October 29, 2018, 12:00 – 1:00 PM 
Where: Albert Sherman Building, AS9-2072 
Save the Date: 2019 8th Annual UMCCTS Community Engagement and Research Symposium 
When: Friday, March 22nd, 2019, 8:15AM-1:30PM 
Where: UMMS, Worcester, MA 
Keynote: Mona N. Fouad, MD, MPH, Senior Associate Dean, Diversity and Inclusion, University of Alabama at 
Birmingham 
Breakout Session Proposals Due: Wednesday, November 21, 2018 5:00 PM  
Please submit your proposal via email to: communityengagement@umassmed.edu with the following 
information: 
• Title of the breakout session  
• Name(s) and affiliation of moderator(s)  
• List of breakout session presenters with email/phone  
• Background and purpose of the breakout session 
• Anticipated format, including a description of how you will interact with the audience 
Notification Date: You will be notified by December 7, 2018 regarding the status of your proposal. 
Questions? Email Communityengagement@umassmed.edu  
For more information, visit our website: www.umassmed.edu/ccts/community  
Registration for the Symposium will open on January 7, 2019 
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What is the Human Research Protection Program (HRPP) Quality Assurance/Quality Improvement 
(QA/QI) program? 
The Human Research Protection Program (HRPP) Quality Assurance/Quality Improvement (QA/QI) program is a 
component of the UMass Center for Clinical and Translational Science. The program is independent of the IRB, and 
helps study teams and investigators by conducting routine post-approval monitoring of ongoing research to evaluate 
adherence with institutional requirements and federal regulations. If there are review findings, the QA/QI manager 
shares those findings with investigators and study team, and provides direct education on the findings, including how 
to avoid making similar errors in the future. In order to support improvement at an institutional level, the QA/QI 
manager shares aggregated data from reviews with the HRPP leadership and the Research Community to identify 
trends and target areas for education. 
The program also makes self-evaluation tools available to investigators and study teams seeking to perform their 
own assessments. 
For a full description of the HRPP QA/QI program, see HRP-142, https://www.umassmed.edu/globalassets/ccts/ccts-
media/irb/updated-sops-2015/hrp-142-hrpp-qa-qi-program-final.pdf  
UMCCTS intake portal, OCR website update 
The UMass Center for Clinical and Translational Science has implemented an intake/service request portal. 
Currently, the portal is being utilized by the Office of Clinical Research for intake of all agreements and amendments, 
OnCore updates/corrections and Certificates of Confidentiality. The portal can be accessed on their newly updated 
website at https://www.umassmed.edu/ocr/  
Recruitment and Retention Toolkit 
The Trial Innovation Network accepts toolkit submissions from CTSAs and reputable community health partners and 
provides them as a free resource to the research community. The materials on this site are designed primarily for 
CTSA Program staffs. These resources are intended to provide a variety of information that includes best practices 
and evidence-based recruitment and retention strategies. 
Full information here: https://trialinnovationnetwork.org/recruitment-retention-toolkit/?key-element=1681  
CTSA Program hubs collaborate to help researchers navigate regulatory environment 
Three North Carolina Clinical and Translational Science Awards (CTSA) Program hubs have collaborated to 
create a platform for sharing regulatory expertise and best practices. The Regulatory Guidance for Academic 
Research of Drugs and Devices (ReGARDD) Program provides researchers with regulatory guidance, 
education, and consultative support, to ultimately help them move promising products and novel discoveries to 
clinical trials. 
ReGARDD, which is coordinated by the hubs at Duke University, the Wake Forest School of Medicine, and the 
University of North Carolina at Chapel Hill (UNC-Chapel Hill) with partner RTI International, officially launched 
in 2015 and has been developing since. The program builds upon the existing services and knowledge of the 
North Carolina CTSA Program Regulatory Groups and the Research Triangle Park (RTP). 
READ THE FULL STORY.  
Visit the ReGARDD Program website. 
National Center for Data to Health (CD2H) 
The goal of CD2H is to make data more meaningful, open, and accessible. The CD2H supports a vibrant and 
evolving collaborative informatics ecosystem for the CTSA Program and beyond. The CD2H harnesses and 
expands an ecosystem for translational scientists to discover and share their software, data, and other 
research resources within the CTSA Program network. The CD2H also creates a social coding environment for 
translational science institutions, leveraging the community-driven DREAM challenges as a mechanism to 
stimulate innovation. 
The CD2H homepage is here: https://ctsa.ncats.nih.gov/cd2h/  
To sign up for their mailing list visit: https://nih.us18.list-
manage.com/subscribe?u=71a7d6465fe8d21880b224d23&id=73804c2f34  
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Have you had research published that cites the UMass Center for Clinical and Translational Science? Has a 
patent been filed on technology developed using Center funding or resources? Did your pilot project receive 
external grant funding? Share it with us at ccts@umassmed.edu . Sharing your successes helps show the 
importance and the effect of the Center for Clinical and Translational Science at UMass.  
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